Noninvasive Vagus Nerve Stimulation for Migraine Treatment: The PRESTO Study

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Clevenger speaks to primary care clinicians, emphasizing 3 priorities: engage family as partners, ask about agitation, and recognize its danger to patient and caregiver.

Sydney Jennings

August 7th 2025

New AHS Emergency Department Migraine Guideline Elevates Prochlorperazine and Nerve Blocks, Advises Again Against Opioids

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Make It Routine: Screening for Cognitive Decline in Primary Care

The revised AHS guideline recommends treatments that offer the strongest benefit at ED discharge and identifies options with limited or no supporting evidence.

Anna Chodos, MD, MPH;Sydney Jennings

July 24th 2025

Longitudinal Blood Biomarkers Show Promise for Monitoring Alzheimer's Disease Progression in Subjective Cognitive Decline

Listen to our latest podcast episode to discover how early dementia detection enhances care and quality of life, with actionable strategies for primary care teams to implement now.

Quality Improvement Program Greatly Expands Sleep Apnea Testing After Stroke in VA Hospitals

Blood-based monitoring could enable earlier intervention as approximately 20% of initially negative participants transitioned to positive biomarker status.

Agitation in Alzheimer Disease: Proactive Assessment and Caregivers' Roles with Carolyn Clevenger, GNP

The study supports the feasibility of structured operational strategies to narrow dangerous gaps in guideline-recommended inpatient OSA testing, authors wrote.

Related Content

Carolyn Clevenger, GNP;Grace Halsey

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Clevenger speaks to primary care clinicians, emphasizing 3 priorities: engage family as partners, ask about agitation, and recognize its danger to patient and caregiver.

Sydney Jennings

August 7th 2025

New AHS Emergency Department Migraine Guideline Elevates Prochlorperazine and Nerve Blocks, Advises Again Against Opioids

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Make It Routine: Screening for Cognitive Decline in Primary Care

The revised AHS guideline recommends treatments that offer the strongest benefit at ED discharge and identifies options with limited or no supporting evidence.

Anna Chodos, MD, MPH;Sydney Jennings

July 24th 2025

Longitudinal Blood Biomarkers Show Promise for Monitoring Alzheimer's Disease Progression in Subjective Cognitive Decline

Listen to our latest podcast episode to discover how early dementia detection enhances care and quality of life, with actionable strategies for primary care teams to implement now.

Quality Improvement Program Greatly Expands Sleep Apnea Testing After Stroke in VA Hospitals

Blood-based monitoring could enable earlier intervention as approximately 20% of initially negative participants transitioned to positive biomarker status.